Oric Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Oric Pharmaceuticals Inc cash flow-to-debt ratio. Oric Pharmaceuticals Inc (ORIC) has a Cash Flow-to-Debt Ratio of -1.35x as of June 2026, meaning its operating cash flow of $-31.61 Million could theoretically repay -1% of its total liabilities ($23.43 Million) in one year. See Oric Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oric Pharmaceuticals Inc (2017–2025)
Cash flow-to-debt ratio of Oric Pharmaceuticals Inc from 2017 to 2025. Historical debt coverage capacity for Oric Pharmaceuticals Inc across 9 annual periods. Also explore net asset growth rate of Oric Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Oric Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
Oric Pharmaceuticals Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Oric Pharmaceuticals Inc. For the full cash flow conversion analysis, see Oric Pharmaceuticals Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.26x | $-113.37 Million | $26.64 Million | ▼ -17.2% |
| 2024 | -3.63x | $-112.66 Million | $31.02 Million | ▼ -29.7% |
| 2023 | -2.80x | $-85.69 Million | $30.60 Million | ▼ -4.4% |
| 2022 | -2.68x | $-75.14 Million | $28.01 Million | ▼ -15.7% |
| 2021 | -2.32x | $-59.54 Million | $25.67 Million | ▲ +52.7% |
| 2020 | -4.91x | $-45.27 Million | $9.22 Million | ▼ -27.6% |
| 2019 | -3.85x | $-23.53 Million | $6.12 Million | ▼ -1967.0% |
| 2018 | -0.19x | $-20.68 Million | $111.16 Million | ▲ +96.2% |
| 2017 | -4.85x | $-20.83 Million | $4.30 Million | — |